Biovail Corp.’s stock price tumbles after the company reports disappointing financial results. Biovail Chairman Eugene Melnyk suspects a conspiracy among short-sellers and analysts to keep the stock price low.
This content has been archived. It is available through our partners, LexisNexis® and Bloomberg Law.
To view this content, please continue to their sites.
For questions call 1-877-256-2472 or contact us at [email protected]